Annex II — Financial tender Financial Evaluation  Title:  Reference:  Lot:  Tenderer (name): COVID-19 vaccine-related studies in long-term care facilities  Vaccine Effectiveness, Burden and Impact Studies of COVID-19 and Influenza OJ/2021/DPR/12924 The table below is automatically filled in from the first sheet. It is not editable. The scenario in the table is only meant for evaluation purposes and does not constitute a commitment on the part of ECDC to request this volume of services. The reference price below must not exceed the estimated maximum budget for this contract: € 2'700'000 Please print/upload BOTH SHEETS (Financial tender and Financial evaluation). Unit price at  coordination level Unit price at study  site level Expected  repetition(s) of  deliverable  Expected Number of  study sites  Total price (unit price x  scenario) € 0 4 € 0 € 0 40 € 0 € 0 4 € 0 € 0 16 € 0 € 0 2 € 0 € 0 8 € 0 € 0 1 € 0 € 0 1 € 0 € 0 2 € 0 € 0 2 € 0 € 0 1 8 € 0 € 0 8 € 0 € 0 4 € 0 € 0 12 8 € 0 € 0 12 € 0 € 0 4 € 0 € 0 4 € 0 € 0 16 € 0 € 0 8 € 0 € 0 4 € 0 € 0 2 € 0 € 0 2 € 0 DL 3.1.6 Reports on progress during each specific contract  Deliverables DL 3.1.1 Annual work plan for thelot, kick-off teleconferencewith ECDC and  minutes provided DL 3.1.2 Minutes of themonthly teleconferences between ECDC and the  contractor DL 3.1.3 Onlineannual meeting (aproximately 50 participants) DL 3.1.4 Onlinetechnical meeting (aproximately 30 participants) DL 3.1.5 Organisation of a faceto facemeeting, including meeting report DL 3.4.3 Scientific materials for outputs on COVID-19 related studies DL 3.1.7 Report/Standard Operating Procedures to transfer knowledgegained  through theproject  DL 3.2.1 Study Protocol DL 3.2.2 Protocol for COVID-19 vaccineeffectiveness in long-term carefacilities DL 3.2.1 Updated list of participating countries and long-term carefacilities  within countries DL 3.3.1 Country specific vaccineeffectiveness protocols. Priceincludes initial  investment in thesetting up thestudy at country level DL 3.3.2 Updateof study related technical documents (such as reporting  protocols, metadata, definitions). Cost of deliverablerefers to methodologial  work performed at coordination level DL 3.3.3 Support implementation of thevaccineeffectiveness study(s) DL 3.3.4 Datasets of data collected in thevaccineeffectiveness study and regular  summary report.  DL 3.3.5 Regular laboratory results summary table. Pricefor up to 2000  individuals*. DL 3.4.1 Annual epidemiological descriptiveand analytical report DL 3.4.2 Draft manuscript inclusiveopen access publication fee DL 3.5.1 Long-term carefacility training/visit (In principleonly virtual trainings,  visits are foreseen. If travel requested by ECDC costs will be reimbursed see  contract articleI.5.3)  DL 3.5.2 Training workshops for long term carefacilities/ information sharing  workshop DL 3.5.3 Report on capacity building DL 3.6.1 Protocols for additional studies within theLTCF (such as Impact  studies, Validation studies, Sensitivity studies) Page 8 of 15